ARCHIVES

FDA Plans to Discuss the Negative Trial of AstraZeneca’s Drug Iressa With the Oncologic Drugs Advisory Committee in March.

This article is from The Cancer Letter archive.

Vol. 31 No. 03 | January 21, 2005

Download PDF Visit The Full Archive

Related Articles

House Appropriations Boosts NIH By $1 Billion In Draft Budget That Cuts Other HHS Programs

September 30, 2011

Albino African Skin Cancer Study To Be Reevaluated

April 11, 1980

Final Issue of ‘76

December 10, 1976

Marijuana Ingredient Promotes Tumor Growth, Study Finds.

June 23, 2000

Possible Budget Balancing Effort Darkens Prospect For Increase In Cancer Budget

March 7, 1980

ACS Honors Cady, Rimer For Work In Cancer Control.

December 8, 2000